HIV Type 1 Subtype CgagandnefDiversity in Southern Africa
- 1 March 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 23 (3), 477-481
- https://doi.org/10.1089/aid.2006.0232
Abstract
Several HIV-1 subtype C-specific gag- and/or nef-based vaccines are currently intended for clinical trial in southern Africa. Here we provide sequences of 64 gag and 45 nef genes sampled in Malawi, Zambia, Zimbabwe, and South Africa and assess the degree of southern African HIV-1 diversity that will confront these vaccines. Whereas reasonable phylogenetic evidence exists for geographical clustering of subtype C gag and nef sequences from various other parts of the world, there is little evidence of similar population founder effects in the southern African epidemic. The entire breadth of subtype C diversity is represented in the southern African genes suggesting there may be no advantage in producing region- or country-specific subtype C vaccines. We do not, however, find much evidence of intersubtype recombination in the Southern African genes, implying that the likelihood of vaccine failure due to the emergence of intersubtype recombinants is probably low.Keywords
This publication has 16 references indexed in Scilit:
- RDP2: recombination detection and analysis from sequence alignmentsBioinformatics, 2004
- Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+T Cells: Correlation with Viral LoadJournal of Virology, 2004
- Combining partial order alignment and progressive multiple sequence alignment increases alignment speed and scalability to very large alignment problemsBioinformatics, 2004
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C InfectionJournal of Virology, 2003
- Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design?Journal of Virology, 2002
- Conserved Domains of Subtype C Nef from South African HIV Type 1-Infected Individuals Include Cytotoxic T Lymphocyte Epitope-Rich RegionsAIDS Research and Human Retroviruses, 2001
- Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Genetic Characterization of HIV Type 1 from Migrant Workers in Three South African Gold MinesAIDS Research and Human Retroviruses, 1998
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996